1. Search Result
Search Result
Results for "

EpCAM

" in MedChemExpress (MCE) Product Catalog:

14

Inhibitors & Agonists

11

Inhibitory Antibodies

19

Recombinant Proteins

4

Antibodies

4

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P99328

    Interleukin Related Inflammation/Immunology Cancer
    Tucotuzumab (Anti-EPCAM Recombinant Antibody) is an antigen-specific IgG1 monoclonal antibody that targets human epithelial cell adhesion molecule (EpCAM). Tucotuzumab links two IL-2 molecules and is an immunosuppressant and anti-tumor active molecule .
    Tucotuzumab
  • HY-P9954

    CD3 Cancer
    Catumaxomab, a trifunctional IgG2 antibody, is composed of mouse and rat heavy and light chains and binds to human EpCAM and human CD 3 receptors. The Fc region of Catumaxomab region has binding affinity for FcγR1 (CD 64), FcγRIIA (CD 32a), and FcγRIII (CD 16). Catumaxomab can be used for anti-tumor research, especially epithelial cancers .
    Catumaxomab
  • HY-RS04420

    Small Interfering RNA (siRNA) Others

    EPCAM Human Pre-designed siRNA Set A contains three designed siRNAs for EPCAM gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    EPCAM Human Pre-designed siRNA Set A
    EPCAM Human Pre-designed siRNA Set A
  • HY-RS23523

    Small Interfering RNA (siRNA) Others

    Epcam Rat Pre-designed siRNA Set A contains three designed siRNAs for Epcam gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Epcam Rat Pre-designed siRNA Set A
    Epcam Rat Pre-designed siRNA Set A
  • HY-RS17079

    Small Interfering RNA (siRNA) Others

    Epcam Mouse Pre-designed siRNA Set A contains three designed siRNAs for Epcam gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Epcam Mouse Pre-designed siRNA Set A
    Epcam Mouse Pre-designed siRNA Set A
  • HY-P99282

    VB6-845; Anti-Human EpCAM Recombinant Antibody Fab Fragment, 17-1A

    Apoptosis Cancer
    Citatuzumab bogatox (VB6-845) is recombinant immunotoxin that composed of Fab fragment of humanized antibody targeting EpCAM and a modified cytotoxin bouganin. Citatuzumab bogatox binds to and selectively induces apoptosis in EpCAM-positive cell lines and shows good activity in EpCAM-positive human tumour xenograft models .
    Citatuzumab bogatox
  • HY-P990862

    CD3 Others
    Anti-CD326/EpCAM Antibody (Ber-EP4) is a kind of mouse IgG1, κ chimeric antibody, targeting to human CD326/EpCAM. The recommend isotype control of Anti-CD326/EpCAM Antibody (Ber-EP4): Mouse IgG1 kappa, Isotype Control (HY-P99977).
    Anti-CD326/EpCAM Antibody (Ber-EP4)
  • HY-P991214

    EMD 273,066; huKS-IL2

    Interleukin Related Cancer
    Tucotuzumab celmoleukin (EMD 273066) is an immunocytokine fusion agent targeting the epithelial cell adhesion molecule (EpCAM). Tucotuzumab celmoleukin binds to EpCAM and delivers IL-2 to the tumor microenvironment, which can activate cytotoxic effector cells, such as CD8+ T cells and natural killer (NK) cells. Tucotuzumab celmoleukin is promising for research of EpCAM-positive cancers, such as colorectal cancer and prostate cancer .
    Tucotuzumab celmoleukin
  • HY-168885

    Apoptosis RAR/RXR Cancer
    ZSH-512 is a potent RARγ inhibitor. ZSH-512 shows antiproliferation activity. ZSH-512 induces apoptosis. ZSH-512 decreases CD133, NANOG, SOX2, and EPCAM protein expression. ZSH-512 shows anticancer activity. ZSH-512 has the potential for the research of colorectal cancer .
    ZSH-512
  • HY-P991034

    CD3 Inflammation/Immunology
    HY-P991034 is an EPCAM/CD3E-targeting H-γ1_L-κ-scFvhl dimer type bispecific antibody .
    Trevotamig
  • HY-P99592

    AMG 110; MT110

    CD3 Cancer
    Solitomab (AMG 110) is a bispecific anti-CD3 and anti-epithelial-cell-adhesion-molecule (EpCAM) antibody. Solitomab can be used for the research of primary uterine and ovarian carcinosarcoma cancer .
    Solitomab
  • HY-111183
    Neocarzinostatin
    1 Publications Verification

    Zinostatin; Vinostatin

    DNA/RNA Synthesis Bacterial Apoptosis Antibiotic Infection Cancer
    Neocarzinostatin, a potent DNA-damaging, anti-tumor antibiotic, recognizes double-stranded DNA bulge and induces DNA double strand breaks (DSBs). Neocarzinostatin induces apoptosis. Neocarzinostatin has potential for EpCAM-positive cancers treatment .
    Neocarzinostatin
  • HY-P990642

    Transmembrane Glycoprotein Inflammation/Immunology
    Oportuzumab is a CHO-expressed humanized antibody that targets EpCAM/TROP1/CD326. Oportuzumab contains a huIgG1 heavy chain and a huκ light chain, with a predicted molecular weight (MW) of 145 kDa. The isotype control for Oportuzumab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).
    Oportuzumab
  • HY-15897
    LDN-212854
    1 Publications Verification

    TGF-β Receptor Cancer
    LDN-212854 is a bone morphogenetic protein (BMP) inhibitor that potently inhibits ALK2 (IC50: 1.3 nM). LDN-212854 also inhibits ALK1 (IC50: 2.40 nM). LDN-212854 can be used in the research of fibrodysplasia ossificans progressive and cancers, such as hepatocellular carcinoma (HCC) .
    LDN-212854

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: